Bio-Rad Laboratories (BIO) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Bio-Rad Laboratories, as the data feed reports them.

Analysts' mean target, 3 analysts
$356.67
0.4% below the price

The 3 analysts reported by the data feed have a mean price target for Bio-Rad Laboratories of $356.67, 0.4% below the $358.19 price (range $280.00–$440.00). 7.21% of the float was sold short as of Oct 30, 2026. Institutions hold 89.7% of the shares and insiders 16.3%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$356.67−0.4% vs price
Analysts
3
Short interest
7.21%of float, Oct 30, 2026
Short ratio
5.09 days
Institutions
89.7%
Insiders
16.29%
Beta
1.06

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

3 analysts covering Bio-Rad Laboratories, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $358.19.

Analysts' price targets for Bio-Rad Laboratories
Mean price target$356.670.4% below the price (−0.4%)
Median price target$350.002.3% below the price (−2.3%)
Highest target$440.0022.8% above the price (+22.8%)
Lowest target$280.0021.8% below the price (−21.8%)
Analysts with a target3

Ratings this month · 3 analysts

Strong buy 1(33%)Hold 1(33%)Strong sell 1(33%)
Analysts' ratings of Bio-Rad Laboratories this month, by rating
RatingAnalystsShare
Strong buy133%
Buy00%
Hold133%
Sell00%
Strong sell133%

The feed averages these to 3 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “hold”.

Who owns Bio-Rad Laboratories

Ownership of Bio-Rad Laboratories
Held by institutions89.7%556 institutions; percent of shares outstanding
Held by institutions, of the float107.2%
Held by insiders16.29%percent of shares outstanding
Shares outstanding21.83M
Float21.51Mshares available to trade
Insiders' net purchases, six months+27.5K15 purchases (30.72K shares), 3 sales (3.22K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Bio-Rad Laboratories
Shares short1.16Mas of Oct 30, 2026
Percent of float7.21%shares short ÷ float
Percent of shares outstanding4.30%shares short ÷ shares outstanding
Short ratio (days to cover)5.09shares short ÷ average daily volume

Bio-Rad Laboratories short interest from FINRA, with its history

Trading figures

Trading figures for Bio-Rad Laboratories
Beta1.06movement against the market; 1 moves with it
52-week high$396.23
52-week low$236.73
Average volume, 3 months255.78Kshares a day
Average volume, 10 days278.23Kshares a day

Questions and answers

What is the analysts' price target for Bio-Rad Laboratories (BIO)?

As reported by the data feed, the mean price target of the 3 analysts covering Bio-Rad Laboratories is $356.67, 0.4% below the latest price of $358.19. The highest target is $440.00 and the lowest $280.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Bio-Rad Laboratories stock?

Of the 3 ratings the data feed reports for the current month, 1 are strong buy, 0 buy, 1 hold, 0 sell and 1 strong sell.

How many Bio-Rad Laboratories shares are sold short?

As reported by the data feed, 1.16M shares were sold short, 7.21% of the float as of Oct 30, 2026. At the average daily volume that is 5.09 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Bio-Rad Laboratories stock?

As reported by the data feed, institutions hold 89.7% of the shares (556 institutions) and insiders 16.3%. There are 21.83M shares outstanding, of which 21.51M are in the float.

How much does Bio-Rad Laboratories stock move with the market?

Its beta, as reported by the data feed, is 1.06: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $236.73 and $396.23.

Cite this page

Funkfolio, “Bio-Rad Laboratories (BIO) statistics and analyst targets”, data as of 17 November 2026. https://funkfolio.com/stock/BIO/statistics

Underlying data: Yahoo Finance.